Lyra Therapeutics, Inc.

Historical 13F Holders

Symbol
LYRA
CUSIP
55234L105
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 55234L105 since 12/18/2024, largest first.

Filer % of Class Filed
Perceptive Advisors LLC 13D/A
15.6% 8/14/2025
Event 8/12/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Nantahala Capital Management, LLC 13G/A
1.1% 11/14/2024
Event 9/30/2024
Citadel Advisors LLC 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 1 300 $26.00
2025 Q1 60 25.6 M $3.23 M
2024 Q4 56 26.9 M $5.54 M
2024 Q3 66 32.6 M $8.37 M
2024 Q2 58 33.6 M $9.29 M
2024 Q1 87 45.8 M $285 M
2023 Q4 67 46.5 M $243 M
2023 Q3 49 31.9 M $125 M
2023 Q2 43 33.7 M $138 M
2023 Q1 34 18.9 M $38.1 M
2022 Q4 42 19.1 M $60.0 M
2022 Q3 40 19.2 M $96.0 M
2022 Q2 39 19.3 M $109 M
2022 Q1 29 5.02 M $20.2 M
2021 Q4 37 8.37 M $36.5 M
2021 Q3 38 6.67 M $60.8 M
2021 Q2 48 10.2 M $81.9 M
2021 Q1 52 10.8 M $125 M
2020 Q4 46 8.60 M $98.0 M
2020 Q3 41 7.66 M $85.7 M
2020 Q2 44 7.04 M $79.8 M